The Neuron: AI Explained

BONUS: OpenAI Workspace Agents 101: Build, Run, and Scale AI Workflows

The Neuron: AI Explained

Show Notes

Join us Thursday as we break down OpenAI’s new Workspace Agents and what they mean for the future of work.

We’ll cover: ⚙️ What workspace agents are 🤖 How they differ from regular chatbots 🏢 Where they fit into real team workflows 🚀 How to start working with them effectively 🔄 What agentic AI means for workplace automation 📈 Why teams are shifting from one-off prompts to repeatable AI-powered processes

Whether you’re experimenting with ChatGPT at work, leading AI adoption, or trying to understand where OpenAI is taking agents next, this session will help you see what’s possible and what to watch for.

Tune in for a practical, hands-on deep dive into the future of AI at work.

Sign up for The Neuron newsletter: https://www.theneuron.ai/

More from The Neuron: AI Explained

Oct 21, 2026

Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.

Oct 16, 2026

OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺

Oct 14, 2026

Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.

Oct 9, 2026

OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.

Oct 8, 2026

Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.

See all episodes →